USA - NYSE:BCAT - US09260U1097
Overall BCAT gets a fundamental rating of 3 out of 10. We evaluated BCAT against 0 industry peers in the Unkown industry. While BCAT seems to be doing ok healthwise, there are quite some concerns on its profitability. BCAT has a expensive valuation and it also scores bad on growth.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 10.08% | ||
ROE | 11.27% | ||
ROIC | 2.37% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 66.67% | ||
PM (TTM) | 248.72% | ||
GM | 70.51% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Altman-Z | 4.55 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 0.06 | ||
Quick Ratio | 0.06 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 9.64 | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 4.32 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 21.19% |
14.65
-0.02 (-0.14%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | 21.19% |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 9.64 | ||
Fwd PE | N/A | ||
P/S | 19.68 | ||
P/FCF | 4.32 | ||
P/OCF | 4.32 | ||
P/B | 0.89 | ||
P/tB | 0.89 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 10.08% | ||
ROE | 11.27% | ||
ROCE | 3.01% | ||
ROIC | 2.37% | ||
ROICexc | 2.37% | ||
ROICexgc | 2.37% | ||
OM | 66.67% | ||
PM (TTM) | 248.72% | ||
GM | 70.51% | ||
FCFM | 455.13% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Debt/EBITDA | N/A | ||
Cap/Depr | N/A | ||
Cap/Sales | N/A | ||
Interest Coverage | 250 | ||
Cash Conversion | N/A | ||
Profit Quality | 182.99% | ||
Current Ratio | 0.06 | ||
Quick Ratio | 0.06 | ||
Altman-Z | 4.55 |